Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q2 2017 · 10-Q
Revenue$4.08M$4.08M+64.1% vs Q2 2016 Net Income-$992.19K-$992.19KN/M vs Q2 2016 EPS Diluted-$0.01-$0.01N/M vs Q2 2016 Gross Profit$2,844,458+70.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flowderived$178,692N/M Free Cash Flowderived$172,282N/M Margins · derivedGross margin69.7%+2.8 pt vs Q2 2016
Operating margin-21.1%+61.9 pt vs Q2 2016
Net margin-24.3%+65.2 pt vs Q2 2016
ended Jun 30, 2017 · filed Aug 11, 2017 · 42 d after period end